Amaro Analytics

Based in the US, Amaro Analytics provides a cutting-edge AI-driven analytics platform that optimizes advertising performance across multiple digital channels, enabling effective decision-making for marketers and executives alike. Founded in 2023 and headquartered in St. Paul, US, Amaro Analytics specializes in analytics solutions for advertising campaigns. The company has completed one deal, with its most recent activity recorded on September 11, 2025.

It was acquired by OpenEvidence, a portfolio company of Kleiner Perkins, Greycroft Partners, GV, Coatue Management, Thrive Capital, and Conviction, although financial terms of the transaction were not disclosed. Amaro Analytics specializes in providing an advanced analytics platform designed to optimize advertising performance across various digital channels. The platform integrates with ad accounts from Meta, TikTok, Reddit, and LinkedIn, offering users a centralized source of truth for their advertising data. By leveraging artificial intelligence, it delivers instant insights and actionable reports that enhance decision-making for marketing teams, creative leads, and executives.

Key features include a workflow library for streamlined reporting, CRM integration for revenue tracking, and an AI Assistant for querying ad performance in natural language. The company serves a diverse clientele, including marketing agencies, brands, and growth-oriented businesses in North America, Europe, and parts of Asia, providing tailored solutions to improve their advertising strategies. Amaro Analytics generates revenue through a subscription-based model, allowing businesses to access its suite of analytics tools and services. Clients engage with the company under various pricing plans that cater to individual marketers, teams, and large enterprises.

The platform's flagship offering includes comprehensive reporting capabilities that support quick analysis of campaign performance, audience engagement, and return on ad spend. This B2B transaction structure fosters ongoing relationships with clients who rely on Amaro for continuous access to up-to-date analytics and performance metrics. The company aims to leverage its recent acquisition by OpenEvidence to integrate its automation technology into a robust healthcare advertising infrastructure, maintaining free access for clinicians. Specific future growth initiatives include expanding its product offerings and enhancing analytics capabilities.

While geographic expansion plans are not currently detailed, the acquisition indicates a strategic focus on strengthening its market position and service offerings in the healthcare sector.